[ad_1]
Primary health care providers should screen the personal, family, and / or ethnic history of bad, ovarian, tubal, or peritome cancers in women to decide who should receive genetic counseling for BRCA1 and BRCA2 mutations. recommended the US Task Force on Prevention Services, [February 19]. Mutations increase the risk of cancer in women.
The draft directive, which is open to public comment for a month, is likely to spark a serene medical debate about how often genetic tests should be used to screen BRCA gene mutations in women.
…
Geneticist Mary-Claire King, who discovered BRCA mutations and their relationship to bad cancer risk in 1990, said she would like every woman to be offered full sequencing of BRCA1 and BRCA2 as part of their care. routine medical.
…
[Genetic testing] allows these women to take steps to reduce their risk, including through enhanced or additional screening, chemoprevention and risk-reducing surgeries.…
"All women, regardless of their personal or family history of cancer, should be offered full sequencing of the BRCA1 and BRCA2 genes as part of routine medical care at about 30 years of age or at their current age if they are already older " [King] I said.
Read the full original message: New recommendations indicate that not all women need genetic testing for cancer. Critics say it could cost lives
Source link
